Abstract--6-Methylmereaptopurine ribonucleoside-5'-phosphate (MeSPuRMP), the sole metabolite of 6-methylmercaptopurine ribonucleoside (MeSPuRib), is a strong inhibitor of purine de novo synthesis, inducing depletion of intracellular purine nucleotides and subsequent cell death in several tumor cell lines. In this study prevention of MeSPuRib cytotoxicity by compounds of the purine salvage pathway was studied in Molt F4 human malignant T-lymphoblasts. Adenosine, adenine and inosine were able to prevent depletion of the adenine nucleotide pool when used in combination with 0.5 (M MeSPuRib, but had virtually no effect on depletion of guanine nucleotides. Nevertheless, these three purine compounds were able to reduce the cytotoxic effects induced by MeSPuRib. Addition of guanosine to cells treated with 0.5/¿M MeSPuRib normalized the guanine nucleotide pool, but adenine nucleotides remained depleted. Under these conditions, inhibition of cell growth was significantly decreased. With the combination of guanosine and IOjwM MeSPuRib, cytotoxicity was increased compared to 10 fiM MeSPuRib alone, associated with a depletion of adenine nucleotides to 9% of untreated cells. Since cell growth and cell viability of Molt F4 cells are less inhibited by MeSPuRib under conditions where adenine nucleotide depletion is prevented by purine compounds (and where the other nucleotides are depleted) we conclude that depletion of adenine nucleotides is an important factor in MeSPuRib MeSPuRib,f an adenosine antimetabolite, is cytoanticancer activity of orally administered 6-MP [19] . toxic for a number of cell lines, and exhibits some
The metabolic route by which 6-MP is generally anticancer activity in vivo [1] [2] [3] [4] [5] . MeSPuRib thought to induce cytotoxicity is conversion into 6-
cytotoxicity is by its met< thioguanine ides, and subse MeSPuRMP, which is formed from MeSPuRib by poration into DNA and RNA [19, 20] . Furthermore, adenosine kinase (Scheme 1) [3, [6] [7] [8] . MeSPuRMP a high activity of thiopurine methyltransferase in is a strong inhibitor of purine de novo synthesis [ 9, 10] red blood cells, resulting in MeSPuRMF at PRPP amidotransferase [9, [11] [12] [13] . Inhibition ot concentrations, correlates with a poor prognosis in this route induces a depletion of purine nucleotides children receiving oral 6-MP therapy, suggesting that [4, 5, [14] [15] [16] , thereby leading to diminution ot RNA tjie méthylation route of 6-MP is a catabolic pathway and DNA formation [14] , and subsequent inhibition [ n , ir] . Our studies of Molt F4 cells, a human of cell growth and loss ot cell viability (3) (4) (5) 15] .
...... ..... lymphoblastic cell line, indicated that MeSPuRMP is also an important metabolite of under conditions where intracellular MeSPuRMP the anticancer agent 6-MP. 6-MP is hnrt conveitet concentrations were elevated, cytotoxicity of 6-mto SIMP and the lattei into MeSPuRM by was increased [21] . Furthermore, cytotoxicity of both 6-MP and MeSPuRib could be reversed in rine met it [17] [18] [19] . 6-MP is commonly used in the oral maintenance treatment of children with acute lymphoblastic leukemia 17, 18] . At present it is under discussion whether cells by addition of amidoimidazolecarboxamide j com is formation to
AICAR, which is an intermediate of purine de novo synthesis distal to the MeSPuRMP inhibition site [22] , providing further evidence for the cytotoxic MeSPuRMP in sd that the cytotoxic effect of MeSPuRMP in these cells is the first step in the purine biosynthetic pathway.
In the present study we obtained more evidence regarding MeSPuRMP cytotoxicity in Molt F4 human T-lymphoblasts. To determine whether MeSPuRib cytotoxicity could be prevented by purine intercarboxamide ribonucleotide; PC A, perchloric acid; IMP, mediates of the purine salvage route (Scheme 1) 
RESULTS

MATERIALS AND METHODS
Treatment of Molt F4 cells with 0.5 fiM MeSPuRib resulted in decreased purine nucleotide con centrations (Table 1 ) and led to inhibition of cell growth and of cell viability (Fig. 1) . The effects of 10 ,uM MeSPuRib on these parameters were similar MeSPuRib, adenosine, adenine, inosine and ( Table 2 and (Table 1) . Adenosine was also able to described earlier [21] . MeSPuRib and adenosine, restore the guanine nucleotide pool after 24 hr. adenine, inosine, guanosine or combinations of Adenine and inosine hardly affected the depletion MeSPuRib with one of these purine compounds of guanine nucleotides ( Table 1) . These purine were added as a single dose in a small volume compounds were able to prevent inhibition of cell growth partially and cell viability nearly completely Intracellular nucleotides (di-and triphosphates) (Fig. 1) . Combination of these purine compounds and MeSPuRMP were extracted from 3 x 106 viable with 10 piM MeSPuRib partly prevented depletion means of perchloric acid (PCA, BDH of the adenine nucleotide pool, especially at 24 hr, Chemicals Ltd, Poole, U.K.) as described earlier but did not prevent the depletion of the guanine [21] and analysed by means of HPLC at a wavelength nucleotide pool ( Table 2) . Cytotoxicity was decreased of 254 nm and 240 nm, respectively [231. The concentrations were expressed as pmoles/lO" viable as a result of addition of these purine compounds to treatment with 10 pM MeSPuRib (Fig. 2) .
Addition of 25 ptM guanosine to treatment with Extracellular nucleosides and bases were extracted 0.5
MeSPuRib resulted in an increase of the from 0.5 mL of the culture medium (after the cells intracellular guanine nucleotide pool, but had no had been removed), to which a volume of 25 juL 8 M effect on the reduction of the adenine nucleotide PCA was added. This was kept on ice for lOmin. pool (Table 1) . If anything, the reduction of the Then the samples were centrifuged for 2 min, after adenine nucleotide pool became more severe, which the supernatant was neutralized with 4M Furthermore, this combination resulted in almost K2HPO4. Nucleosides and bases were determined normal cell viability (Fig. lb) , and cell growth was by means of reversed-phase HPLC, with a Supelcosil only partly affected (Fig. la) . In contrast, guanosine LC-18-DB column (25 cm X 4.6 mm, Supelco, in combination with 10 juM MeSPuRib led to a large 
O ^o increase of cytotoxicity as compared to 10 //.M MeSPuRib alone (Fig. 2) . Under these conditions intracellular adenine nucleotides were depleted to 9% of untreated cells after 24 hr ( Table 2) .
Timo (h)
To gain an insight into the metabolic fate of the purine compounds after addition to the cells alone, or in combination with MeSPuRib, concentrations of extracellular nucleosides and bases were determined. The results of these experiments are shown in Table  3 . Adenosine can be incorporated via two pathways: directly by adenosine kinase and indirectly by conversion into inosine, which is then converted into hypoxanthine, and subsequently into IMP (Scheme 1). The operation of this second route was reflected by extracellular inosine and hypoxanthine after addition of 50 /uM adenosine to Molt F4 cells (Table 3) . No extracellular adenosine . When inosine is used, it catabolized to hypoxanthine, which is subsequ phosphorylated by hypoxanthine phoribosyltransferase to IMP. Both hypoxanthine were detectable in the medium for the first 6 hr after the start of the experiment (Table  3) . Adenine is meti by adenine phosphoribosyltransferase to adenine S'-monophosphate (AMP), and is present in the medium until 48 hr (Table 3 ). After addition of guanosine and guanine are present (Table 3) . In general the disappearance of the added (Fig. 3a) . With lO^uM addition of adenosine, adenine and inosine resulted concentration. in a in a However, addition of guanosine MeSPuRMP concentration after 48 hr as compared to 10 uM ib alone (Fig. 3b) . j c u s r activity after conversion to MeSPuRMP, a strong inhibitor of purine de novo synthesis [9, 10) . In this study the effects of MeSPuRib on Molt F4 human T-lymphoblasts have been determined. Inhibition of cell growth, cell viability and purine concentrations (Fig. 1 (Table 2 ). This may be attributed normal cell growth and cell viability (Fig. 1, Table to two phenomena. First, when adenosine is used in  1) . The effects of these three purine compounds on combination with a high concentration of MeSPuRib, purine nucleotide concentrations are comparable. competition for adenosine kinase may occur, since The initial normalization during the first 24 hr of both adenosine and MeSPuRib are metabolized by intracellular adenine nucleotides is followed by this enzyme (Scheme 1). As a result, less adenosine depletion ( Table 1) . This is the result of the very can be phosphorylated by the cells. This process is rapid conversion of the purine bases and nucleosides, reflected by the prolonged presence of extracellular as determined by the rapid disappearance of these hypoxanthine (Table 3) , a product of adenosine compounds and their derivates from the incubation catabolism, which indicates a slow anabolism of medium (Table 3) . Reversal of the effects of 3 /aM adenosine under these conditions. Second, it is MeSPuRib on induction of differentiation, cell known that a high MeSPuRMP concentration results growth inhibition and purine nucleotide con-in inhibition of PRPP synthetase [24,27,28]. As centrations by various concentrations of adenine was PRPP is a substrate for the enzymes adenine Reversal of 6-methylmercaptopurine ribonucleoside cytotoxicity phosphoribosyltransferase and hypoxanthine guan-MeSPuRib for adenosine kinase, since ine phosphoribosyltransferase and thus is involved compounds are metabolized by this enzyme. It is at in the metabolism of adenine and inosine (the latter present not clear how addition of adenine, inosine being first converted into hypoxanthine), less adenine and MeSPuRMP ation. and inosine will be incorporated into the cells with Perhaps these purine compounds interfere with the 10/uM MeSPuRib. Again, this is reflected by transport of MeSPuRib, thereby
•'"•''asing the concentrations of extracellular and concentration of intracellular MeSPuRib and hypoxanthine after treatment with 10 /¿M MeSPuRib MeSPuRMP. in combination with either inosine or adenine (Table  In conclusion, depletion of intracellular adenine  3) .
nucleotide concentration appears an important factor The minor effects of adenine, adenosine and in MeSPuRib cytotoxicity. This is in contrast with inosine on the intracellular guanine nucleotide pool earlier observations that the biological consequences caused by 0.5 jUM and 10 ¿iM MeSPuRib (Tables 1 of purine starvation as a r and 2) are probably the result of a preferential treatment were primarily due to guanine nucleotide
>n in a mouse TMoreover, conversion of bases and nucleosides into a result of addition of adenosine, adenine and guanine nucleotides is a much slower process than to treatment with MeSPuRib, the adenine nuc conversion into adenine nucleotides [29] .
were restored to nearly normal values The severe cytotoxicity observed with the first 24 hr of treatment, whereas guanine nucleotides combination of lO^uM MeSPuRib and 2 5 /iM remained depleted (Tables 1 and 2) , and nucleotides (data not shown) became deple it consumption of î ascribed to a nearly is a purine 25 ftM guanosine (Fig. 2) can t complete reduction in intracellular adenine nucleo tides, which is induced by several mechanisms. First, salvage intermediates. Since cell growth and cell inhibition of purine de novo synthesis by MeSPuRib viability of Molt F4 cells still partly recovered to will result in a depletion of adenine nucleotides, control values under these conditions, restoration of Second, MeSPuRib is converted into MeSPuRMP the depletion of adenine nucleotides is also important by the enzyme adenosine kinase, a reaction which for amelioration of the effects of inhibition of purine consumes ATP and thus induces a further decrease de novo synthesis by MeSPuRib.
Furthermore, it appears of importance to use at least two concentrations of MeSPuRib to study the effects of purine salvage intermediates on MeSPuRib 48 hr (Table 2 ). The formation of GDP and GTP induced cytotoxicity, since this reveals more of the from GMP consumes ATP by kinase reactions, underlying mechanisms of cytotoxicity.
of adenine nucleotide concentrations. Third, addition of guanosine leads to an increase in guanine nucleotides 2.5 times that of the control value at Therefore the adenine nucleotide will guanosine was reported earlier [15, 30, 31] , and was explained by these authors as a synergistic action between GMP and MeSPuRMP, resulting in a more severe inhibition of presumably at PRPP amidotransferase [30] . The results of our study do not confirm this conclusion, since the guanine nucleotide pools are also elevated novo s with the ation of 0.5 guanosine, which does not lead to a more severe depletion of adenine nucleotides as compared to 0.5 /.iM MeSPuRib alone ( Table 1) . Rather the more the combination of 10 ¿uM MeSPuRib and guanosine is the result of the severe depletion of the adenine nucleotide pool observed under these conditions. Since the conversion of ribose-5'-phosphate to PRPP is ATP dependent, severe depletion of ATP may lead to less availability of PRPP for purine de novo synthesis [24).
The decrease in MeSPuRMP concentrations as a result of addition of adenosine as treatment with MeSPuRib alone (Fig. 2) may be the to result of competition idenosine and 1
